Know Labs (NYSEAMERICAN:KNW) Shares Up 3.8% – What’s Next?

Know Labs, Inc. (NYSEAMERICAN:KNW) rose 3.8% during mid-day trading on Monday . The company traded as high as $2.17 and last traded at $2.1390. 612,050 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Stock Performance

The stock’s 50 day moving average price is $2.14 and its 200 day moving average price is $2.14. The company has a market capitalization of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83.

Institutional Trading of Know Labs

An institutional investor recently bought a new position in Know Labs stock. Corient Private Wealth LLC acquired a new position in Know Labs, Inc. (NYSEAMERICAN:KNW) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned approximately 0.67% of Know Labs at the end of the most recent quarter. 23.96% of the stock is owned by institutional investors and hedge funds.

Know Labs Company Profile

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.